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ABSTRACT 17 
 18 
Here we present two types of all-printable, highly stretchable, and inexpensive devices 19 
based on platinum (Pt)-decorated graphite for glucose determination in physiological 20 
fluids. Said devices are: a non-enzymatic sensor and an enzymatic biosensor, the latter 21 
showing promising results. Glucose has been quantified by measuring hydrogen 22 
peroxide (H2O2) reduction by chronoamperometry at -0.35 V (vs pseudo-Ag/AgCl) 23 
using glucose-oxidase immobilized on Pt-decorated graphite. The sensor performs well 24 
for the quantification of glucose in phosphate buffer solution (0.25 M PBS, pH 7.0), 25 
with a working range between 33 M and 0.9 mM, high sensitivity and selectivity, and 26 
a low limit of detection (LOD). Thus it provides an alternative non-invasive and on-27 
body quantification of glucose levels in human perspiration. This biosensor has been 28 
successfully applied on real human perspiration samples and results also show a 29 
significant correlation between glucose concentration in perspiration and glucose 30 
concentration in blood measured by a commercial glucose meter. 31 
 32 
Keywords: glucose biosensor; printed electronics; stretchable device; H2O2; catalyst; 33 
perspiration. 34 
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1. Introduction 1 
 2 
Diabetes is a chronic disease with overwhelming human, social and economic 3 
consequences. It is caused by insufficient insulin production or secretion, which 4 
impedes the ability of cells to digest glucose from the blood. Seven million people 5 
develop diabetes annually and the World Health Organization (WHO) has forecast a 6 
50% increase in the number of diabetes-related deaths over the next decade (Wang and 7 
Lee, 2015). Although there is no way to cure or prevent diabetes, appropriate 8 
monitoring and quantification of glucose levels can improve treatment efficiency and 9 
simplify patient lifestyle. As a result, there is substantial interest in electrochemical 10 
sensors for glucose detection and quantification. Most of these electrochemical sensors 11 
are enzyme-based, and depend on invasive blood sampling techniques (Cui et al., 2001; 12 
Harborn et al., 1997; Zhu et al., 2002). Even modern glucose meters, like the popular 13 
Accu-Check®, rely on the measurement on blood samples (Galant et al., 2015). The 14 
painful finger-stick is the main drawback leading to patient non-compliance and also 15 
makes it impossible to achieve real-time information required for some biomedical 16 
applications. Therefore, major scientific effort is being made to develop non-invasive 17 
glucose monitoring diagnostic tools (Liu et al., 2015; Lodgotra et al., 2016; Rabti et al., 18 
2016). For instance, human perspiration offers valuable information about health status 19 
depending on the levels of several analytes, like lactate, ammonium, and glucose 20 
(Labroo and Cui, 2013; Mitsubayashi et al., 1994). Interestingly, glucose monitoring 21 
provides a correlation between glucose levels in blood and perspiration for diabetic 22 
patients, with concentration ranging between 10 M and 0.7 mM, the common 23 
perspiration glucose concentrations of hypoglycaemic and hyperglycaemic patients as 24 
well as healthy people (Moyer et al., 2012; Lee et al., 2016; Sakaguchi et al., 2013). 25 
Development of soft, stretchable and body-integrated glucose sensors has the potential 26 
to address the lack of devices for real-time monitoring of glucose levels. Taking into 27 
account that the human epidermis is continuously subjected to bending and stretching 28 
movements during common physical activity, skin-worn stick-on sensors must have 29 
high resilience. As a result, Wang and co-workers focused on the development of 30 
wearable electrochemical devices able to monitor several target analytes in 31 
physiological fluids, like saliva, tears or perspiration (Bandodkar et al., 2016, 2015; Jia 32 
et al., 2013; Kim et al., 2015). 33 
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First we present the development of a highly stretchable Pt-decorated graphite based 1 
non-enzymatic glucose sensor. To our knowledge this is the first example of a stick-on 2 
Pt nanoparticles (Pt-NPs) based stretchable non-enzymatic electrochemical sensor. The 3 
highly stretchable nature and enzyme-free glucose detection offered by the Pt-NPs ink 4 
developed in this study provides an attractive alternative to the present blood glucose 5 
meters for developing body-worn sensors for real-time, non-invasive diabetes 6 
management. In the present study, Pt-decorated graphite was used as the ink filler. Pt-7 
NPs have high electro-activity, even with low amounts of the platinum metal on the 8 
electrode, thus keeping the cost of the device low (Peng and Yang, 2009; Zhang et al., 9 
2016). 10 
Although the enzyme-free electrochemical determination of glucose concentration is the 11 
most desirable, the selectivity and sensitivity can be greatly enhanced by the 12 
immobilization of glucose oxidase (GOx). This enzyme contains the flavin adenine 13 
dinucleotide cofactor (FAD), the active center where glucose oxidation takes place 14 
(Wilson and Turner, 1992). First-generation biosensors are based on the use of oxygen 15 
as electron acceptor and the ensuing generation and quantification of H2O2 (Bankar et 16 
al., 2009; Wang, 2008). The presence of Pt within the stretchable electrodes permits the 17 
detection of H2O2 at less positive potentials and thus minimizes interference by electro-18 
active species, such as, ascorbic acid (AA) or uric acid (UA), which are electro-active at 19 
more positive potentials (Prabhu et al., 1981). Despite these benefits, most of the first-20 
generation biosensors were developed to detect H2O2 oxidation and few studies can be 21 
found on the electrochemical detection of glucose based on H2O2 reduction (Pu et al., 22 
2016; Wang et al., 1994). This represents the first example of a stretchable 23 
electrochemical sensor able to detect glucose in perspiration samples by measuring 24 
reduction of H2O2 with the lowest cathodic potential. The sensors are based on graphite 25 
decorated with Pt and GOx (GOx/Pt-graphite biosensor) (Figure 1A). This sensor is 26 
useful for real-time, non-invasive enzymatic detection and quantification of glucose by 27 
H2O2 reduction in perspiration. The skin-worn sensor reported here has been 28 
successfully applied to real human perspiration samples, proving an attractive route for 29 
the non-invasive detection of glucose. 30 
 31 
2. Materials and methods 32 
 33 
2.1. Reagents and apparatus 34 
 35 
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Graphite black powder was purchased from ACROS OrganicsTM (A Thermo Fisher 1 
Scientific), isophorone was obtained from Alfa Aesar, flexible stretchable fabric glue 2 
polymer (binder) from Aleene´s, silver/silver chloride ink (E2414) from Ercon Inc. 3 
Silver epoxy adhesive was bought from Electron Microscopy Sciences. 4 
Hexacloroplatinic acid (H2PtCl6), sodium borohydride (NaBH4), Ecoflex® 00-30 5 
(Smooth-On, Inc., PA), temporary transfer tattoo paper (HPS Papilio, Rhome, TX), 6 
polyurethane (PU) (Tecoflex SG-80A), potassium ferricyanide, chitosan from crab 7 
shells, glucose oxidase from Aspergillus niger, bovine serum albumin (BSA), Nafion® 8 
117 solution 5%, glucose, uric acid (≥99%, crystalline), L-ascorbic acid (reagent grade, 9 
crystalline), dopamine hydrochloride, and epinephrine standard chemicals, were 10 
provided by Sigma-Aldrich. Potassium dihydrogen phosphate (KH2PO4) and 11 
dipotassium hydrogen phosphate (K2HPO4) obtained by Emsure® and Sigma-Aldrich 12 
respectively, were used to prepare buffer solutions. Sodium hydroxide (NaOH) was 13 
purchased from Merk. Glacial acetic acid for analysis was obtained from Panreac. 14 
Ultrapure water was obtained by a treatment in Purelab Ultra Elga with a resistivity of 15 
18 MΩ cm. A Contour XT® glucose meter and strips Contour®Next were purchased 16 
from Bayer. 17 
Ecoflex® 00-30 was prepared by mixing equal volumes of pre-polymer A with pre-18 
polymer B provided by the supplier. Similarly, conductive silver epoxy adhesive was 19 
prepared by mixing equal volumes of two parts provided by the supplier.  20 
Transmission electron microscopy measurements (TEM) were carried out using a JEOL 21 
TEM, JEM-2010 model, which is equipped with an Oxford X-ray detector (EDS), 22 
INCA Energy TEM 100 model, and GATAN acquisition camera. Scanning electron 23 
micrographs were taken using an ORIUS SC600 model Field Emission Scanning 24 
Electron Microscope (FE-SEM) using a ZEISS microscope, Merlin VP Compact model, 25 
with an EDX Bruker, Quantax 400 model. 26 
X-ray photoelectron spectroscopy (XPS) was performed using a VG-Microtech 27 
Multilab 3000 spectrometer using non-monochromatized MgKα (1253.6 eV) radiation 28 
from a twin anode source operated at 300 W (20 mA, 15 kV). Photoelectrons were 29 
collected in a hemispherical analyzer working in the constant energy mode at the pass 30 
energy of 50 eV. The binding energy (BE) of the C ls peak at 286.4 eV was taken as 31 
internal standard. 32 
 33 
 34 
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2.2. Preparation of the sensors 1 
 2 
2.2.1. Pt-decorated graphite synthesis and purification 3 
 4 
Pt-NPs were synthesized on the graphite support by following a reduction method at 5 
room temperature and atmospheric pressure. In order to achieve 4% (w/w) of Pt-NPs on 6 
graphite support, the following procedures were applied:  7 
Solution I, 0.6 g of graphite was added to 2 mL of distilled water in a glass container. 8 
The solution was maintained under stirring conditions for 12 hours to achieve 9 
homogeneous dispersion. After that, 4 mL of hexachloroplatinic acid (H2PtCl6, 30 mM) 10 
was added to solution I and stirred for an hour. 11 
Solution II (85 mg mL-1 NaBH4) was slowly added to solution I and stirred for 2 hours 12 
in order to reduce most of the Pt precursor. 13 
The prepared nanoparticles deposited on graphite were purified by vacuum filtration, 14 
washed with an excess of ethanol and, finally, the solid obtained was dried in an oven at 15 
60ºC for 30 min.  16 
 17 
2.2.2. Preparation of the inks 18 
 19 
Three different inks were used for the further printing of the working electrode (WE), 20 
counter electrode (CE) and pseudo-reference electrode (RE). 21 
For WE preparation, a 75% Pt-graphite/25% binder (w/w) ink was prepared as follows: 22 
100 mg of Pt-Graphite powder was well mixed with 30 mg of stretchable binder to 23 
ensure a good homogeneity. Next, 200 µL of isophorone was added to the mixture in 50 24 
L aliquots and manually mixed (Figure 1B). Employing the same method, an ink 25 
comprising 75% graphite/ 25% binder (w/w) was prepared for further printing of the 26 
CE.  27 
Finally, a commercial silver/silver chloride (Ag/AgCl) ink was used as RE, with 10% of 28 
Ecoflex® to ensure stretchability of the final device. The inks were electrochemically 29 
characterized by cyclic voltammetry (Figure S1) and various physicochemical 30 
techniques (Figure S2). 31 
 32 
2.2.3. Preparation of the sensors 33 
 34 
As illustrated in Figure 1C, sensor preparation involves the screen printing of inks on a 35 
polyurethane (PU) sheet, previously modified, as shown below. Sensor patterns were 36 
designed in AutoCAD and outsourced for manufacture on stainless steel through-hole 37 
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12” x 12” framed stencils of 125 m thickness. Initially, a screen printing of a thick 1 
layer of Ecoflex® was done on a temporary transfer tattoo paper and allowed to half-2 
cure for two hours at room temperature. After that, Ecoflex® was carefully placed on a 3 
PU sheet, where Ecoflex® curing was completed, ensuring proper contact between the 4 
two polymers. Special attention was paid to this step to avoid the appearance of air 5 
bubbles or wrinkles during attachment of the Ecoflex® layer onto the PU sheet. After 6 
that, a temporary transfer tattoo paper was used to cover the Ecoflex® layer and 7 
subsequently, the protective paper on top of the PU sheet was removed to exhibit the 8 
PU layer. Two types of devices were printed. The simple one consists of a printed line 9 
of Pt-graphite ink, or graphite ink, which acts as working electrode (Pt-graphite line 10 
electrode and graphite line electrode), with Ag/AgCl and a wire of Pt being external 11 
reference and counter electrodes, respectively. This kind of device was employed to 12 
optimize all parameters of the proposed method (see supplementary information). The 13 
second device was made by successive manual printing of stretchable Ag/AgCl 14 
(pseudo-reference electrode and serpentine interconnects), stretchable graphite (counter 15 
electrode) and Pt-decorated graphite (Pt-graphite, working electrode) inks to produce 16 
the whole electrochemical sensor (stretchable Pt-graphite sensor, Figure 1C). The 17 
printed stretchable Ag/AgCl was cured at 90ºC for 4 min, and stretchable graphite and 18 
Pt-decorated graphite were cured at 50ºC for 30 min, all in a convection oven. Finally, 19 
an Ecoflex® layer was printed to define the electrode area and contact pads were bound 20 
to the serpentine interconnects by using silver epoxy ink as a conductive adhesive. The 21 
final device was cured at 65ºC for 10 min and kept at room temperature until use. 22 
 23 
2.2.4. Preparation of amperometric glucose biosensors  24 
 25 
Glucose biosensors (GOx/Pt-graphite line electrode and GOx/Pt-graphite biosensor) 26 
were manufactured by functionalizing the Pt-graphite with GOx enzyme (Figure 1A). 27 
To improve the GOx immobilization on the Pt-graphite electrode, the surface of the WE 28 
was covered with 1.5 L of chitosan solution (0.5 wt%, 0.1 M acetic acid) and allowed 29 
to dry at room temperature. Next, 4.3 L of a solution of GOx in PBS (34 mg mL-1) 30 
containing BSA (15 mg mL-1) as enzyme stabilizer, was added to the same area. When 31 
the electrode surface was completely dry, 6 L of 5% Nafion® was added. The 32 
modified sensor was kept at 4ºC until use. 33 
 34 
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 1 
Figure 1. A) Diagram illustrating the design of the stretchable sensor, the enzymatic 2 
immobilization on the printed catalytic layer, and the reaction during detection. The inset shows 3 
a real image of a screen-printed sensor. B) Preparation of the screen-printable, stretchable and 4 
catalytic ink. C) Screen-printing process showing layers of the components. 5 
 6 
 7 
2.3. Electrochemical methods 8 
 9 
All electrochemical measurements were carried out on a BIOLOGIC SP-300 10 
potentiostat. All potentials presented are referred to the Ag/AgCl electrode. A three-11 
electrode configuration was used, with three different designs. Firstly, a glassy carbon 12 
(GC) electrode modified with Pt-graphite powder was used as WE in order to 13 
characterize the synthesized material, an external Ag/AgCl as RE and a Pt wire as CE. 14 
This was the only experiment performed in a nitrogen atmosphere. The second design 15 
consisted of a printed line of graphite, Pt-graphite or GOx/Pt-graphite as WE, an 16 
external Ag/AgCl as RE and a Pt wire as CE. The last design employed was the 17 
stretchable electrochemical biosensor (GOx/Pt-graphite biosensor) comprised of a 18 
GOx/Pt-graphite WE, a graphite CE and a stretchable printed Ag/AgCl pseudo-19 
reference electrode. All measurements were taken in an air atmosphere, unless 20 
otherwise stated. 21 
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Cyclic voltammetry was used to characterize the material synthesized and to determine 1 
the reduction potential for H2O2. Quantification of H2O2 and glucose were carried out 2 
by chronoamperometry. The glucose sensor was calibrated in the glucose concentration 3 
range between 10 M and 0.9 mM, levels corresponding to the typical perspiration 4 
glucose concentration (Lee et al., 2016; Moyer et al., 2012). All measurements were 5 
carried out in PBS (0.25 M, pH 7.0) and in triplicate (n = 3). 6 
For real samples determination, filtered human perspiration was used and no other 7 
treatment was carried out.  8 
 9 
3. Results and Discussion  10 
 11 
3.1. Pt-decorated graphite line sensors. Glucose oxidation 12 
 13 
Electrochemical non-enzymatic glucose detection was performed with a Pt-graphite 14 
printed line electrode. Figure 2A shows the voltammograms obtained for the Pt-graphite 15 
line electrode in PBS (dashed line) and 80 mM glucose solution (solid line) in which the 16 
reduction peaks at 0 V and -0.8 V related to the reduction of platinum oxide and 17 
hydrogen evolution reaction, respectively, are clearly visible in the reverse scan. In the 18 
presence of glucose, two anodic currents appear in the cyclic voltammogram. The first 19 
one, at -0.4 V, corresponding to the “hydrogen region”, is related to glucose oxidation at 20 
a potential where adsorbed hydrogen exits on the platinum surface. It should be noted 21 
that glucose produces the unique behavior of electrochemical oxidation in the hydrogen 22 
region when Pt is used as a working electrode (Park et al., 2006). The second one 23 
corresponds to the oxidation peak that appears in the “double layer region”, at around 24 
0.1 V (Park et al., 2006). These results agree with the literature since it is proposed that 25 
glucose oxidation on platinum in neutral phosphate buffer involves the dehydrogenation 26 
at C1 carbon, showing two anodic signals (Park et al., 2006).  27 
Chronoamperometry was performed with the Pt-graphite line electrode for glucose 28 
concentrations between 0 mM and 82 mM at 0.2 V and -0.4 V. The corresponding 29 
calibration curves obtained are shown in Figure 2B.  30 
 31 
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Figure 2. A) Cyclic voltammogram for Pt-graphite line electrode in PBS (0.25 M, pH 7.0) 2 
(dashed line) and in glucose 80 mM (solid line). Inset: magnified zone. B) Calibration curves 3 
obtained from chronoamperometry representing the linear range at -0.4 V (solid line) and at 0.2 4 
V (dashed line).  5 
 6 
 7 
Analytical parameters are given in Table 1. The LOD was determined empirically, by 8 
progressively measuring more diluted concentrations of the analyte. The LOD was the 9 
lowest concentration whose signal could be clearly distinguished from the blank. 10 
Moreover, the LOQ was calculated as 3.3 times the LOD (LOQ = 3.3LOD). 11 
Additionally, coefficient of variation (CV) values were obtained for 3 replicates at 61 12 
mM of glucose (Miller, J. and Miller, J.C., 2010). 13 
 14 
Table 1. Analytical figures of merit for glucose quantification with Pt-graphite line electrode at -15 
0.4 V and 0.2 V and GOx/Pt-graphite biosensor at -0.35 V. 16 
 17 
Parameter 
Pt-graphite  
line 
GOx/Pt-graphite 
biosensor 
-0.4 V 0.2 V -0.35 V 
Sensitivity (A cm-2 mM-1) 0.69  0.06 0.24  0.02 105  3 
Intercept (A cm-2) -175  3  -5.6  0.9 10.9  1.4 
r 0.996 0.999 0.992 
N 6 6 13 
n 3 3 3 
Linear range (mM) 0 -82 0-82 0.0-0.9 
LOD (mM) 6.6 4.8 0.010 
LOQ (mM) 21.8 15.9 0.033 
CV (%) 
(n = 3; C = 61 mM) 
5.7 7.7 9 
 18 
A 
B 
10 
 
Glucose levels in perspiration fluids are lower than the LOD achieved with this 1 
electrode, therefore these results are not applicable to perspiration samples. However, 2 
the proposed sensor may be used to quantify glucose in other physiological fluids like 3 
blood where glucose levels can reach 19 mM in diabetic patients (Moyer et al., 2012). 4 
Although enzyme-free electrochemical determination of glucose concentration is 5 
preferable, enzyme use can greatly improves the lack of selective catalytic activity and 6 
low sensitivity towards glucose, which is due to the slow kinetic of glucose oxidation. 7 
Enzymatic quantification of glucose through H2O2 reduction should improve the 8 
sensitivity and LOD compared to glucose quantification with the non-enzymatic 9 
containing electrode. To accomplish this aim, we first evaluated the behavior of graphite 10 
and Pt-graphite line electrodes towards H2O2 reduction (Figure S3). 11 
 12 
3.2. Pt-graphite line biosensors. Glucose detection. 13 
 14 
Electrochemical behavior of GOx/Pt-graphite line electrode towards glucose additions 15 
was investigated by cyclic voltammetry and chronoamperometry. Figure 3A shows the 16 
voltammograms obtained with the GOx/Pt-graphite line electrode in PBS (dashed line) 17 
and in a solution of glucose 25 mM (solid line). The peaks related to H2O2 oxidation 18 
and reduction are clearly visible at 0.6 V and -0.2 V, respectively, indicating that 19 
glucose oxidation is catalyzed by GOx, producing H2O2 by the further re-oxidation of 20 
GOx by molecular oxygen. In order to find the optimum potential at which sensitivity 21 
towards H2O2 reduction is the highest, chronoamperometry was performed at 0.0 V, -0.1 22 
V and -0.2 V. According to the sensitivity values (results not shown), it was decided to 23 
perform the chronoamperometry at -0.2 V. Figure 3B inset includes the j-t curves 24 
obtained for successive additions of glucose, with concentrations between 0.01 mM and 25 
5 mM.  26 
Chronoamperometries were performed three times at each concentration in order to 27 
determine analytical parameters. The calibration curve is shown in Figure 3B. 28 
11 
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Figure 3. A-B) Electrochemical behavior of GOx/Pt-graphite line electrode: A) cyclic 5 
voltammograms in PBS (0.25 M, pH 7.0) (dashed line) and in PBS containing 25 mM glucose 6 
(solid line), vscan = 0.05 V s-1, B) calibration curve obtained representing the linear range. Inset: 7 
j-t curves at -0.2 V obtained on increasing glucose concentrations: 0 mM (a), 0.01 mM (b), 0.05 8 
mM (c), 0.1 mM (d), 0.25 mM (e), 0.5 mM (f), 0.75 mM (g), 1 mM (h), 2 mM (i), 3 mM (j), 4 9 
mM (k) and 5 mM (l), Ei = 0 V, Ef = -0.2 V. C-F) Electrochemical behavior of the stretchable 10 
GOx/Pt-graphite biosensor: C) cyclic voltammograms in PBS (0.25M, pH 7.0) (dashed line) and 11 
in 0.9 mM glucose solution (solid line); vscan = 0.05 V s-1, D) calibration curve representing the 12 
linear range. Inset: j-t curves at -0.35 V obtained on increasing glucose concentrations from 0 13 
mM (a) 0.01 mM (b), 0.03 mM (c), 0.05 mM (d), 0.1 mM (e), 0.2 mM (f), 0.3 mM (g), 0.4 mM 14 
(h), 0.5 mM (i), 0.6 mM (j), 0.7 mM (k), 0.8 mM (l) and to 0.9 mM (m), Ei = 0.0 V, Ef = -0.35 15 
V. E) Evaluation of enzyme immobilization by Michaelis constant. F) j-t curve showing the 16 
effect at spiking level of 10 M AA, 5 M UA, 1 M DP and 0.5 M EPI on a solution 17 
containing glucose 100 M at -0.35 V. Ei = 0.0 V. 18 
 19 
 20 
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3.3. Stretchable GOx/Pt-graphite biosensor 1 
 2 
Before GOx immobilization, in order to ensure that the device is applicable to human 3 
skin and the deformations experienced, stretching tests were performed to determine the 4 
maximum strain sensors can withstand without losing their detection properties. Device 5 
stretchability was evaluated by resistance measurements and by cyclic voltammetry of 6 
K4Fe(CN)6 probe. The results show that the device can be elongated up to 75% of its 7 
initial length without variations in its electrochemical behavior (Figure S4). Moreover, 8 
it has been checked that the sensor can be fixed on human skin. 9 
 10 
3.3.1.  Glucose detection in standard solutions 11 
 12 
 Figure 3C presents the voltammograms obtained between -1.1 V and 0.6 V for the 13 
GOx/Pt-graphite biosensor in a PBS solution (dashed line) and in a glucose solution 0.9 14 
mM (solid line). In the presence of glucose, cathodic and anodic waves are observed at -15 
0.35 V and 0.0 V, corresponding to the reduction and oxidation of H2O2, respectively. 16 
Concerning the stretchable GOx/Pt-graphite biosensor, the cathodic signal related to 17 
H2O2 appears at lower potentials (-0.35 V vs -0.2 V) due to the Ag/AgCl pseudo-18 
reference electrode used. 19 
Chronoamperometry at -0.35 V was carried out for the glucose concentration range 20 
between 10 M and 0.9 mM in PBS (Figure 3D inset), and the corresponding 21 
calibration curve is shown in Figure 3D. 22 
Due to the heteroscedastic data obtained (Figure 3D), a weighted regression model was 23 
applied. It is noteworthy that such data processing is not only used to determine the 24 
slope and the intercept of the calibration plot or the concentration of samples, but also to 25 
estimate the confidence limits for those concentrations. These are much more realistic 26 
than those obtained by the unweighted regression method (Miller, J. and Miller, J.C., 27 
2010). The LOD was determined empirically, by progressively measuring more diluted 28 
concentrations of the analyte. The LOD was the lowest concentration whose signal 29 
could be clearly distinguished from the blank. Moreover, the LOQ was calculated as 3.3 30 
times the LOD (LOQ = 3.3LOD). The CV values were obtained for 3 replicates at 0.5 31 
mM glucose concentration (Miller, J. and Miller, J.C., 2010). All analytical parameters 32 
obtained for the reported method are shown in Table 1. This enzymatic detection 33 
significantly improved sensitivity and LOD compared to the method using direct 34 
glucose oxidation on Pt-graphite line electrode (Figure 2B and Figure 3D). The new 35 
13 
 
biosensor proved adequate for the normal levels of glucose in perspiration fluids for 1 
diabetic patients (Moyer et al., 2012).  2 
The developed stretchable biosensor greatly improves both the electrochemical and 3 
analytical parameters obtained with other biosensors using similar electroactive material 4 
to that used in the proposed biosensor. Kudo et al. (Kudo et al., 2006) developed a 5 
flexible biosensor based on a platinum working electrode able to quantify H2O2. 6 
However, the amount of glucose was quantified by applying a much higher potential 7 
(0.55 V), with the consequent interference of AA and UA. Besides, the sensitivity they 8 
obtained was lower than that achieved in the present work. Another flexible glucose 9 
sensor based on graphene (Kwak et al., 2012) achieves adequate sensitivity, but with a 10 
working range between 3.3 mM and 10.9 mM. These levels are higher than glucose 11 
levels in samples to which these stick-on sensors can be applied, like perspiration or 12 
tears, and have been improved with the proposed stretchable biosensor. Table S1 shows 13 
a more extensive comparison between glucose biosensors reported in the last years with 14 
the GOx/Pt-graphite biosensor developed in this work. 15 
Moreover, in order to evaluate the efficiency of GOx immobilization, we found that the 16 
double reciprocal plot (Figure 3E) could be correlated with the Lineweaver–Burk 17 
equation: 18 
Equation (1)      
1
Iss
=
1
Imax
+
Km
app
Imax𝐶𝑔𝑙𝑢𝑐𝑜𝑠𝑒
 19 
 20 
Where Iss is the steady-state current reached after glucose addition, Cglucose is the glucose 21 
concentration in the bulk and Imax is the maximum current observed at glucose 22 
saturation. The apparent Michaelis constant Km
app was evaluated to be at around 1.2 mM, 23 
which is lower than the values obtained from GOx in solution and in agreement with 24 
reported enzymatic GOx-based sensor (Vagin et al., 2016). This result illustrates the 25 
effective immobilization as the low Km
app value of the electrode shows the high affinity 26 
towards glucose substrate. 27 
Biosensor specificity was studied considering that perspiration consists of a plethora of 28 
metabolites and electrolytes (Harvey et al., 2010). The stretchable GOx/Pt-graphite 29 
biosensor was evaluated towards potential interferences commonly present in 30 
physiological fluids by studying their effect at -0.35 V. AA, UA, DP and EPI were 31 
added in a 100 M glucose solution, to reach concentrations of 10 M, 5 M, 1 M, 32 
and 0.5 M, respectively (Figure 3F), which are higher than the common concentration 33 
14 
 
of these analytes in human perspiration samples (Ancel Keys, 1934). No interference 1 
from these biochemical compounds was observed. Note that the perturbation in the j-t 2 
curve after the addition of different aliquots is due to the homogenization of the 3 
solution. However, the current is recovered in a few minutes reaching the initial current 4 
density. 5 
Stretching tests were performed to determine the maximum strain that the GOx/Pt-6 
graphite biosensor can withstand without losing its glucose detection performance. 7 
Figure S4C shows the images of the GOx/Pt-graphite biosensor for strain levels 8 
between 0% and 75%. Figure S4D presents the j-t curves obtained after strain levels of 9 
25%, 50% and 75% were applied 50 times each. A CV of 1.3% (Cglucose = 0.9 mM; n = 10 
4) was obtained, indicating that the GOx/Pt-graphite biosensor could be subjected to a 11 
strain of 75% without significant modifications of its sensing properties. 12 
 13 
3.3.2. Human perspiration samples 14 
 15 
Perspiration samples were collected from five healthy volunteers (men and women in 16 
their twenties) with no medical history of diabetes after an intense sport session and 17 
were investigated by chronoamperometry at -0.35 V. The final application of the 18 
biosensor is to be fixed to the human skin; however, the sensors were tested in the 19 
analysis of perspiration samples collected in glass containers by volunteers. Perspiration 20 
samples were filtered to eliminate solid contamination by skin collected by the 21 
volunteers during sampling. No dilution or treatment was performed to simulate 22 
sampling conditions during real-time measurement. The glucose concentrations 23 
calculated are shown in Table 2. No matrix effects were found allowing the use of the 24 
external calibration curve obtained above for all samples measured (Figure 3D). Also, 25 
the perspiration sample from subject I was used to evaluate inter-sensor reproducibility 26 
by using three different biosensors, giving a CV of 23%. This value, which is due to the 27 
handmade biosensor printing process, could be greatly reduced by the use of a printing 28 
machine during sensor manufacture. Trueness of the method was checked by measuring 29 
the glucose concentration in perspiration samples speaked at 0.4 mM of glucose, 30 
leading a recovery between 71 and 84% (Table 2). Even though GOx activity is 31 
dependent on pH (optimal values between 5.0 and 7.0) and temperature (optimal values 32 
between 25-60 ºC) (Bankar et al., 2009), the results obtained for glucose recoveries 33 
indicate that these parameters do not significantly vary the enzyme activity. 34 
15 
 
 1 
Table 2. Determination of glucose in real perspiration samples 2 
Subject 
Initial 
(mM) 
Spiked 
(mM) 
Found 
(mM) 
Recovery 
(%) 
I 0.27  0.06 0.4 0.56  0.05 83 
II 0.14  0.06  0.4 0.38  0.07 71 
III 0.31  0.07 0.4 0.59  0.11 84 
IV 0.17  0.07 0.4 0.46  0.09 81 
 3 
Perspiration sample from subject V was taken to compare glucose levels obtained under 4 
fasting and post-meal conditions, giving concentrations of (0.14  0.06) mM and (0.53 5 
 0.10) mM, respectively. Perspiration sample under fasting conditions was collected 12 6 
h after the last food intake, while the post-meal sample was collected 30 min after 7 
substantial glucose intake. In both cases, perspiration samples were gathered after 30 8 
min of intense sport activity. The results show large differences between glucose levels 9 
under fasting and post-meal conditions. 10 
Currently, there is no commercially available diagnostic tool for measuring glucose 11 
levels in perspiration. Therefore, to compare and benchmark the performance of the 12 
biosensor developed in this work, we used a Contour XT®glucose measurement meter 13 
from Bayer, a commercially available diagnostic tool for measuring glucose in 14 
peripheral blood. This analysis was done for a limited number of samples (i.e., 6 15 
samples). Blood samples of volunteers were collected prior to the sport activities 16 
necessary to generate the perspiration samples. To do so, a time interval of 30 min was 17 
observed between the perspiration and blood samples collection. To quantify the 18 
correlation between the concentrations in both fluids, we used the R2-value of 19 
regression analysis for the correlation between the response of the sensors under 20 
development and the response from the Contour XT® results. Figure 4 presents the 21 
correlation plot, where the sensors showed an R2-value of 0.968, indicating a significant 22 
correlation in the results obtained.  23 
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Figure 4. Comparison of Contour XT® glucose meter (CGLU BLOOD ) and our biosensor (CGLU 2 
PERSPIRATION ) using regression analysis for perspiration and blood samples. 3 
 4 
 5 
4. Conclusions 6 
 7 
In the present work, an all-printable, highly stretchable, and low-cost device, based on 8 
Pt-decorated graphite (stretchable Pt-graphite sensor, 3 %wt Pt), was developed for non-9 
invasive glucose monitoring in physiological fluids. The synthesized Pt-graphite 10 
electrode was exhaustively characterized by cyclic voltammetry, TEM, FE-SEM and 11 
XPS.  12 
Glucose in phosphate buffer solution (0.25 M PBS, pH 7.0) was investigated by two 13 
different methods: non-enzymatic and enzymatic detection. On the one hand, enzyme-14 
free detection was carried out by recording the glucose oxidation current by 15 
chronoamperometry at -0.4 V and 0.2 V. The results obtained at negative potential show 16 
the higher sensitivity of this method. The sensitivity obtained with this sensor was 0.69 17 
± 0.06 µA cm-2 mM-1, and a LOD of 6.6 mM. Given the LOD achieved, this non-18 
enzymatic sensor is useful to detect glucose in physiological fluids like blood, where 19 
glucose levels are higher than in other human fluids like perspiration.  20 
On the other hand, enzymatic detection was performed after immobilization of GOx on 21 
a Pt-decorated graphite electrode (GOx/Pt-graphite biosensor). Glucose quantification 22 
in this case, was done by measuring the current of H2O2 reduction via 23 
chronoamperometry at -0.35 V. The latter method greatly improved the sensitivity 24 
levels obtained with the enzyme-free sensor. Excellent results have been obtained for 25 
glucose quantification in phosphate buffer solution (0.25 M PBS, pH 7.0), where the 26 
GOx/Pt-graphite biosensor exhibits a low LOD of 10 M with a linear range between 0 27 
M and 0.9 mM. The sensitivity obtained with this enzymatic sensor was 105  3 A 28 
cm-2 mM-1. Repeatability was studied for a glucose concentration of 0.5 mM providing 29 
R2 = 0.968 
17 
 
a CV of 9%. No interferences of UA, AA, DP and EPI were observed, confirming the 1 
high specificity of the sensor for glucose. Stretchability tests were performed to study 2 
the influence of stress-strain on detection performance. The results show that the 3 
GOx/Pt-graphite biosensor can be stretched up to 75% of its original size with a CV for 4 
glucose detection of 1.3% and it has been checked that the sensor can be fixed in human 5 
skin.  6 
Inter-sensor reproducibility and the trueness of the proposed method were investigated 7 
by the analyses of human perspiration samples, providing a CV of 23% and a recovery 8 
between 71% and 84%. Moreover, statistically significant differences were found in the 9 
glucose levels obtained from perspiration samples collected under fasting and post-meal 10 
conditions. Finally, results obtained by measuring glucose concentrations in human 11 
perspiration with a GOx/Pt-graphite biosensor and human blood with a commercial 12 
glucose meter indicate a significant correlation between these values. 13 
These data indicate that the present stretchable biosensor is competitive, making it an 14 
alternative stick-on, non-invasive device for the continuous quantification of glucose 15 
levels in human perspiration samples. 16 
 17 
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